Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

NCT07712913 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
348
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Brainfarma Industria Química e Farmacêutica S/A